Results 291 to 295 of about 948,853 (295)
Some of the next articles are maybe not open access.
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Nature Reviews Clinical Oncology, 2018Daniel E Johnson, Jennifer R Grandis
exaly
[TF (tissue factor), TFPI (tissue factor pathway inhibitor)].
Nihon rinsho. Japanese journal of clinical medicine, 2005Yoshitaka, Mori, Hideo, Wada
openaire +1 more source
DNA double-strand break repair-pathway choice in somatic mammalian cells
Nature Reviews Molecular Cell Biology, 2019Ralph Scully +2 more
exaly
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Nature Reviews Cancer, 2019Jonathan J Havel +2 more
exaly
The evolving landscape of tissueâagnostic therapies in precision oncology
Ca-A Cancer Journal for CliniciansVivek Subbiah +2 more
exaly

